Beranda › Kanker Esofagus › California › Los Angeles
Uji klinis Kanker Esofagus di Los Angeles, CA
15 studi untuk Kanker Esofagus mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Menerima pesertaFase 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Menerima pesertaFase 1/2
- UCLA Hematology/Oncology - Santa Monica ( Site 4905), Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
- University of Southern California, Los Angeles
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Menerima pesertaFase 3
- UCLA, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Menerima pesertaFase 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
Menerima pesertaFase 1/2
- UCLA Hematology/Oncology - Santa Monica ( Site 8905), Los Angeles
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
Menerima pesertaFase 1/2
- UCLA Hematology/Oncology - Santa Monica ( Site 6905), Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Menerima pesertaFase 1
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Menerima peserta
- Oncology Institute for Hope and Innovation, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Menerima peserta
- Cedars-Sinai Medical Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Menerima pesertaFase 1/2
- University of Southern California, Los Angeles
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Menerima pesertaFase 4
- Cedars-Sinai Medical Center, Los Angeles
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- UCLA Medical Center, Los Angeles
Uji klinis Kanker Esofagus di kota lain
- Houston, TX36 studi
- Boston, MA23 studi
- New York City, NY22 studi
- Nashville, TN19 studi
- St. Louis, MO17 studi
- Pittsburgh, PA15 studi
- Grand Rapids, MI14 studi
- Baldwin Park, CA14 studi
- Philadelphia, PA13 studi
- San Antonio, TX12 studi
- Rochester, MN11 studi
- Chicago, IL11 studi
Studi lain di Los Angeles
- Kanker Paru Non-Sel Kecil87 studi
- Kanker (semua jenis)74 studi
- Kanker Payudara73 studi
- Kanker Prostat61 studi
- Kanker Kolorektal59 studi
- Kanker Metastatik57 studi
- Kanker Ovarium50 studi
- Kanker Paru45 studi
- Karsinoma Sel Skuamosa Kepala dan Leher42 studi
- Kanker Pankreas35 studi
- Kanker Endometrium34 studi
- Melanoma34 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.